BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

BIOCHEM BIOPH RES CO

ISSN / eISSN

0006-291X / 1090-2104

目标和范围

Biochemical and Biophysical Research Communications is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. The development of the "Breakthroughs and Views" section brings the minireview format to the journal, and issues often contain collections of special interest manuscripts. BBRC is published weekly (52 issues/year).Research Areas now include: Biochemistry; biophysics; cell biology; developmental biology; immunology
; molecular biology; neurobiology; plant biology and proteomics

研究方向

生物物理

生化与分子生物学

CiteScore

6.10

查看趋势图

CiteScore 学科排名

类别	分区	排名
Biochemistry, Genetics and Molecular Biology - Biophysics	Q2	#37/143
Biochemistry, Genetics and Molecular Biology - Biochemistry	Q2	#185/428
Biochemistry, Genetics and Molecular Biology - Molecular Biology	Q3	#193/380
Biochemistry, Genetics and Molecular Biology - Cell Biology	Q3	#150/274

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE	Q3
BIOPHYSICS - SCIE	Q2

H-index

243

出版国家或地区

UNITED STATES

出版商

Academic Press Inc.

出版周期

Weekly

出版年份

1959

年文章数

1340

Open Access

通讯方式

ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, USA, CA, 92101-4495

同领域相关热门期刊
近期发表文章

Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer: (2023) Yong Jin, Ying Xia, Hong Du, Tingting Xiang, Bingxue Lan, Sixi Wei, Hongyu Li, Hai Huang

Protective effects of villi mesenchymal stem cells on human umbilical vein endothelial cells by inducing SPOCD1 expression in cases of gestational diabetes mellitus: (2023) Dawei Wang, Zhenying Wei, Fangfei Lin, Yiqian Wang, Xiaogang Liu, Qiuyi Li, Lin Sun, Shengmei Yang

Generation and characterization of PDGFRα-GFP knock-in mice for visualization of PDGFRα+ fibroblasts in vivo: (2023) Xueying Yang, Xufeng Li, Zhihou Guo, Zhuonan Zhang, Xin Song, Mingjun Zhang, Ximeng Han, Lingjuan He, Bin Zhou

UK-5099, a mitochondrial pyruvate carrier inhibitor, recovers impaired neutrophil maturation caused by AK2 deficiency in human pluripotent stem cell models: (2023) Jingxin Wang, Norikazu Saiki, Ayako Tanimura, Takafumi Noma, Akira Niwa, Tastutoshi Nakahata, Megumu K. Saito

The structure of MucD from Pseudomonas syringae revealed N-terminal loop-mediated trimerization of HtrA-like serine protease: (2023) Ju Hyeong Kim, Gwan Hee Lee, Jae-Hee Jeong, Yeon-Gil Kim, Hyun Ho Park

Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells: (2023) Daria V. Lysikova, Valeria Y. Vasileva, Vladislav I. Chubinskiy-Nadezhdin, Elena A. Morachevskaya, Anastasia V. Sudarikova

Promising applications of phyto-fabricated silver nanoparticles: Recent trends in biomedicine: (2023) Yugal Kishore Mohanta, Awdhesh Kumar Mishra, Jibanjyoti Panda, Ishani Chakrabartty, Bhaskar Sarma, Sujogya Kumar Panda, Hitesh Chopra, Gokhan Zengin,...

Andrographolide induced heme oxygenase-1 expression in MSC-like cells isolated from rat bone marrow exposed to environmental stress: (2023) Reza Alipanah-Moghadam, Maryam Khodaei, Vahideh Aghamohammadi, Vadoud Malekzadeh, Mehdi Afrouz, Ali Nemati, Hoda Zahedian

How does TCR-T cell therapy exhibit a superior anti-tumor efficacy: (2023) Dandan Yang, Zhihui Duan, Ping Yuan, Chengming Ding, Xiaoming Dai, Guodong Chen, Daichao Wu

An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment: (2023) Fu-Ling Chang, Cheng-Chung Lee, Keng-Chang Tsai, Tsai-Yu Lin, Chen-Wei Chiang, Shiow-Lin Pan, Yu-Ching Lee

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

The status of "submitted to journal" lasted for about 15 days, during which I kept checking other people's information. I saw that someone else was in the same status and got rejected, which made me very anxious. Then suddenly, it changed to "under review" and this status lasted for about 10 days. And one morning, I woke up and saw an acceptance letter.

So, being in the "submitted to journal" status for a long time doesn't necessarily mean rejection. It is possible that there are simply too many submissions for them to handle. Everyone, keep going and good luck.

2023-05-12

Extremely fast. The first submission, including the review and modification process, was accepted within a month. This time, the additional materials for the Chinese language were submitted in the afternoon and were accepted right away. I can't believe it.

2022-09-08

查看所有评论

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.